BYD-AUTO
28.9.2022 15:36:40 CEST | Business Wire | Press release
BYD announces the pre-sale prices of its new European passenger car range. The world’s leading manufacturer of new energy vehicles and power batteries immediately introduces three full-electric passenger vehicles which will be delivered to Norway, Sweden, Denmark, the Netherlands, Belgium, Luxembourg and Germany. Before the end of the year customers in France and the United Kingdom will also have access to BYD’s zero-emission vehicles. After that, more dealers will be appointed supporting BYD’s plans to cover all major markets in Europe.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220928005587/en/
BYD Europe Product Premiere 2022
The pre-sale price for the BYD ATTO 3 is € 38,000. The BYD HAN and TANG pre-sale prices are € 72,000. These pre-sale prices apply to Germany as a reference for Europe and may differ from country to country. The three full-electric BYD vehicles are technologically advanced and well-suited to the expectations and needs of European customers. The BYD HAN, BYD TANG and BYD ATTO 3 will be exhibited at this year’s Paris Motor Show in October 2022.
For BYD Chairman Wang Chuanfu, who founded the company in 1995, the BYD European passenger market launch is one of the most important milestones to date. “Europe is the birthplace of the auto-industry and has a strong spirit of innovation. Europeans are making a concerted effort to accelerate the transformation of automobile electrification, with Europe representing the main driving market for the advancement of new energy vehicles. As such, we are pleased that BYD can now grow electric car adoption simultaneously with the local markets. We look forward to working together with respected European dealers and industry partners to create high-end quality products with green technology, and bring diversified choices and experiences to more consumers.’’
Designed with European Customers in Mind
While advanced technology underpins every BYD vehicle, attention to detail and cultural references are pivotal to BYD’s design ethos. BYD design merges thousands of years of Chinese culture with modern European culture using the expressive Chinese dragon face for aesthetic inspiration for its passenger car range. This distinctive design language combines with stylish features and innovative technology to meet modern lifestyle expectations.
BYD will start the European launch with three full electric vehicles. The spacious BYD ATTO 3 is designed with the European customer in mind and is the first SUV built on BYD’s advanced e-Platform 3.0. This C-segment SUV shows BYD EV innovation (standard heat-pump) combining aesthetics, intelligence, and efficiency with an array of safety features including the Blade Battery. The interior is a truly digital, connected experience. BYD Global Designer Wolfgang Egger and his team created an expressive and fun design, with a touch of novelty. BYD ATTO 3 is, with its distinctive silhouette and alloy wheels, a real eye-catcher in its category. It is a versatile and appealing choice for many European consumers. BYD ATTO 3 has a 60.48 kWh battery and offers a reassuring 420 kilometre range (WLTP).
BYD HAN is striking in appearance from every angle. The sleek and sporty sedan embodies style and premium finish inside and out, while offering an exhilarating driving performance and superb responsiveness. The BYD HAN has two electric motors, generating a true all-wheel-drive system for safety and handling. The combined power of the dual motor system delivers an impressive 380 kW or 516 horsepower with a 0-100km/h sprint time of just 3.9 seconds. The BYD HAN offers a high-tech, premium experience benefiting from some of the EV industry’s most advanced technologies, including the revolutionary Blade Battery.
Another product delivering a premium experience, yet this time with 7 seats, is BYD TANG. This large all-wheel drive vehicle has made an impressive entry into the competitive electric SUV market segment since its launch in BYD’s pilot-market in Norway last year. The zero-emission 7-seater combines exciting performance with comfort, space, efficiency and safety. The BYD TANG delivers an all-round premium experience, complete with high specification as standard. Also the BYD TANG is equipped with the ultra-safe, state-of-the-art Blade Battery, designed for optimal safety, performance, durability and efficiency. Acceleration is exciting too, from 0-100km/hr in just 4.6 seconds.
“The BYD design is expressive and emotional, as well as clean and relevant,” says BYD Global Designer Wolfgang Egger. “Designing BYD HAN and BYD TANG we were inspired by the dragon face, a strong character in Chinese culture, and with BYD HAN, with the beauty of a European sports car. Furthermore, we strived to create a clean, 3D like, feeling with a classic edge. For the design of BYD ATTO 3 we wanted to create a very fresh, spacious and youthful feeling to attract young people and families. Once again with BYD ATTO 3 we were inspired by the Chinese dragon, which we call the Dragon Face Design language. Its distinctive moustache, the skin and the dragon eyes are all elements that are portrayed in BYD ATTO 3. Our inspiration for some of the interior elements we found in the gym and in music. For instance, the door handles, the armrests and fenders were inspired by barbells and different gym equipment. In the door panels we constructed strings and when you touch these they also sound like a guitar. Rather amusing, they also have a practical function for storage”.
BYD Expertise in Power Batteries and Pioneering Core Technology
It is BYD’s world-leading innovation in technology that is integral to BYD’s electric passenger vehicles. Over the past decades, BYD has focused on mastering advanced technologies spanning cobalt free BYD Iron-Phosphate batteries, electric motors, electronic control systems and automotive-grade chips.
Emerging from this considerable research and development is the ground-breaking Blade Battery which is revolutionizing safety, durability and performance in the EV industry. This works in close synergy with BYD’s competency in electric powertrain technology (BYD has developed an ultra-intelligent next-generation e-Platform 3.0) for the ultimate in system efficiency and integrated vehicle intelligence. Combined, this integrated technology has been developed to deliver optimum performance and a better driving experience. Notably, BYD owns the vertical supply chain of EVs for seamless integration and manufacturing control, including the production of semiconductors.
BYD Offers 8-year Power Battery Warranty
Michael Shu, General Manager and Managing Director, BYD Europe and International Cooperation Division, says: “Technological innovation needs to be safe, reliable, comfortable, and accessible. This is what we are striving for. European customers have high demands on their mobility solutions and in view of this, we have prepared our market launch with care. BYD comes to Europe with a full range of new electric cars, that lives up to the high expectations of our customers. We introduce vehicles that are reliable, practical, and comfortable with premium equipment as a standard feature. Such is our confidence in our technology and quality of our vehicles, our cars come with an 8-year power battery warranty.”
Accordingly, Michael Shu looks forward to sharing the benefits of BYD electric cars with other European countries. “We have high respect for the European auto industry and its ecosystem, including design, R&D, manufacturing, sales, aftersales network, and services. Our strategy is to work with established and respected local dealers who share our vision, to provide high-levels of customer service.”
HD Photos: https://we.tl/t-kDqhBtGlhe
BYD Product Highlights
Items |
BYD ATTO 3 |
BYD TANG |
BYD HAN |
Dimension (L/W/H) |
4,455/1,875/1,615 |
4,870/1,950/1,725 |
4,995/1,910/1,495 |
Drive type |
FWD |
AWD |
AWD |
Top speed (km/h) |
160 |
180 |
180 |
Motor power (kW) |
150 |
380 |
380 |
0-100km/h acceleration time (s) |
7,3 |
4,6 |
3,9 |
Wheel size (inch) |
18 |
22 |
19 |
Electric range (km) |
420 (WLTP combined) |
400 (WLTP combined) |
521(WLTP combined) |
Trunk volume (L) |
440/1,338 |
235/940/1,655 |
410 |
Seating capacity (occupants) |
5 |
7 |
5 |
Battery type |
BYD Blade Battery (LFP) |
BYD Blade Battery (LFP) |
BYD Blade Battery (LFP) |
Rated capacity (kWh) |
60,48 |
86,4 |
85,4 |
DC charging time (30-80%, min) |
29 |
30 |
30 |
Panoramic sunroof |
Standard |
Standard |
Standard |
- Detailed specifications will be announced close to the official introduction at the Paris Motor Show.
About BYD
BYD is a multinational high-tech company devoted to leveraging technological innovations for a better life. Founded in 1995 as a rechargeable battery maker, BYD now boasts a diverse business scope covering automobiles, rail transit, new energy, and electronics, with over 30 industrial parks in China, the United States, Canada, Japan, Brazil, Hungary, and India. From energy generation and storage to its applications, BYD is dedicated to providing zero-emission energy solutions that reduce global reliance on fossil fuels. Its new energy vehicle footprint now covers 6 continents, over 70 countries and regions, and more than 400 cities. Listed in both Hong Kong and Shenzhen Stock Exchanges, the company is known to be a Fortune Global 500 enterprise that furnishes innovations in pursuit of a greener world.
BYD Europe is headquartered in the Netherlands and is the first overseas branch of BYD Group, with a commitment to evolving the international brand BYD Auto to deliver safe and efficient sustainable solutions in new energy vehicles through world-leading technological innovations.
For more information, please visit www.byd.com.
About BYD Auto
Founded in 2003, BYD Auto is the automotive subsidiary of BYD, a multinational high-tech company devoted to leveraging technological innovations for a better life. Aiming to accelerate the green transition of the global transportation sector, BYD Auto focuses on developing pure electric and plug-in hybrid vehicles. The company has mastered the core technologies of the entire industrial chain of new energy vehicles, such as batteries, electric motors, electronic controllers, and automotive-grade semiconductors. It has witnessed in recent years significant technological advancements, including the Blade Battery, the DM-i and DM-p hybrid technology, the e-Platform 3.0, and the CTB technology. The company is the world’s first carmaker to stop the production of fossil-fueled vehicles on EV shift and has remained top of new energy passenger vehicle sales in China for 9 years in a row.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220928005587/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Rapid Medical™’s TIGERTRIEVER™ 13 Demonstrates Promising 90-Day Outcomes in DISTALS Trial, Reinforcing Pivotal Safety and Efficacy Findings7.5.2026 14:03:00 CEST | Press release
Full data presented at ESOC 2026 further strengthen the clinical evidence supporting TIGERTRIEVER™ 13 for the treatment of distal vessel occlusion stroke — a segment representing nearly half of all ischemic strokes Rapid Medical™, a leading developer of advanced stroke treatment devices, today announced full results from the DISTALS randomized clinical trial, presented at the 11th European Stroke Organisation Conference (ESOC) in Maastricht, Netherlands, showing that TIGERTRIEVER™ 13 can safely restore blood flow to the brain and may improve clinical outcomes in patients with distal and medium vessel occlusion (DMVO) stroke. These findings build on earlier results showing a threefold improvement in restoring blood flow compared with medical management alone (p<0.0001), with no cases of serious brain bleeding observed in the treatment group. “These results show we can now safely restore blood flow and suggest this will make a meaningful difference for the right patients,” said Jeffrey L
2 Million Downloads in Six Months: Tabelog’s Multilingual App Solves Critical Dining Pain Points for Travelers to Japan7.5.2026 14:00:00 CEST | Press release
“Eat Where Locals Eat” Making authentic Japanese dining experiences accessible to global travelers through instant reservations at over 70,000 restaurants nationwide. Tabelog (https://tabelog.com/en/), one of Japan’s largest (*1) restaurant search and reservation services operated by Kakaku.com, Inc., has announced that its multilingual smartphone app (iOS/Android) for travelers visiting Japan has reached 2 million downloads (*2). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260507560248/en/ 2M+ Downloads in 6 Months. The app also ranked #1 in downloads among Restaurant Search Apps in Japan for International Travelers (*3) in Taiwan, Hong Kong, South Korea, and the U.S., reflecting its immense popularity among global visitors. Download URL: https://tabelog-tourists.onelink.me/3eEh/iqkkho9r The Trusted Choice for Global Travelers: Solving Two Major Dining Pain Points in Japan For years, international visitors to Japan have
Altasciences and Certara Announce Strategic Partnership to Accelerate Early Drug Development7.5.2026 14:00:00 CEST | Press release
Altasciences, a fully integrated drug development solution company, andCertara (Nasdaq: CERT), a global leader in model-informed drug development (MIDD), today announced a strategic partnership to accelerate early-phase development programs. Fewer than half of preclinical drug candidates successfully reach first-in-human trials. Failures are driven by toxicity, poor pharmacokinetics, lack of efficacy, and challenges translating results from animals to humans. Many of these risks can be mitigated through a fully integrated model-informed drug development approach. Building on Altasciences’ Acceleration Platform, the integration of Certara’s strategic drug development services and biosimulation technology enables sponsors to establish proof of mechanism earlier, design more efficient studies, and make informed go/no-go decisions with greater confidence. By embedding modeling insights and digital workflows directly into development execution, study designs are optimized, dosing strategies
FIFA and Fanatics Expand Wide-Ranging Relationship to Include Historic Exclusive Collectibles Agreement (Trading Cards, Stickers and Trading Card Games)7.5.2026 13:00:00 CEST | Press release
Partnership includes FIFA tournaments and events from 2031Agreement encompasses both physical and digital collectibles, and for the first time brings the player jersey patch program to international footballPre-match press conferences for the FIFA World Cup Final to take place at Fanatics Fest on Friday, 17 July 2026 In a landmark agreement expanding their already successful wide-ranging commercial relationship, FIFA and Fanatics have signed a long-term, exclusive collectibles licensing deal that features trading cards, stickers, and trading card games. The agreement, which will begin in full in 2031, covers both physical and digital collectibles. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260507105628/en/ An example of the product innovations that will be brought to fans under this new partnership is the highly sought-after player jersey patch program, including debut patches, which will be inserted into football tradin
DEFINITIVE Trial Reaches Major Milestone: All Centres Approved and More Than 50% Recruitment Achieved7.5.2026 11:21:00 CEST | Press release
Poster presented at ESMO Breast Cancer 2026: Exploring health policy and real-world treatment strategies for early-stage HER2-positive breast cancer across Europe. The DEFINITIVE project, a landmark European Union-funded international phase III clinical trial evaluating the use of the HER2DX diagnostic assay to guide personalised treatment in early-stage HER2-positive breast cancer (BC), announces two major operational milestones at the ESMO Breast Cancer 2026 congress. Approvals have been obtained in the 7 participating countries, 33 clinicals sites are now open for patient recruitment. The trial has reached over 50% of its recruitment target, marking a pivotal moment on the path toward to transforming HER2-positive BC treatment. About the DEFINITIVE Project The DEFINITIVE project is a 5-year, prospective, open-label, randomised, two-arm phase III international clinical trial conducted across 44 centres in 7 European member states and associated countries. The trial aims to demonstrat
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
